MyTrials.ai key facts
- Developer of an AI-powered clinical trial matching platform designed to connect patients with studies that match their health profiles, preferences, and values.
- It has raised $3.5M; the latest was Seed Round ($3.5M) in Dec 2024.
- Notable investors include Front Row Ventures, Providence Health Care Ventures, Health Innovation Hub.
- Status: Privately Held (backing).
Who backs MyTrials.ai
3- ·Watch MyTrials.ai: the Monday email on marks, rounds and moves
MyTrials.ai funding rounds
No funding rounds for MyTrials.ai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
MyTrials.ai investors
3 investors are on record for MyTrials.ai, including Front Row Ventures, Providence Health Care Ventures and Health Innovation Hub.
About MyTrials.ai
Developer of an AI-powered clinical trial matching platform designed to connect patients with studies that match their health profiles, preferences, and values. The company's platform provides streamlined tools for identifying eligible participants, reducing recruitment timelines, and improving trial outcomes, to match individuals with suitable clinical trials, enabling researchers and clinical trial organizations to simplify enrollment and enhancing access to potentially life-saving treatments.
- Sector
- Healthcare
- HQ
- Vancouver, Canada
- Founded
- 2024
- Employees
- 4
- Website
- mytrials.ai/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
MyTrials.ai doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.